|
| | 2-[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methylthio-1H-benzimidazole Basic information |
| Product Name: | 2-[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methylthio-1H-benzimidazole | | Synonyms: | 2-[[3-Methyl-4-(2,2,2-trifluoroethoxy)pyridine-2-yl]methylthio]-1H-benzoimidazole;2-[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinylmethylthio]-1H-benzoimidazole;2-[3-Methyl-4-(2,2,2;Lansoprazole Related Compound B (25 mg) (2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-pyridin-2-yl]methyl]sulfanyl]-1H-benzimidazole);2-{[3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]Methyl}-1H-1,3-benzodiazole-1-thiol;2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)Methyl)thio)-1H-benzo[d]iMidazole;2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]Methyl]thio]-;1H-BenziMidazole, 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]Methyl]thio]- | | CAS: | 103577-40-8 | | MF: | C16H14F3N3OS | | MW: | 353.36 | | EINECS: | 1533716-785-6 | | Product Categories: | Heterocycles;Intermediates & Fine Chemicals;Imidazol&Benzimidazole;Metabolites & Impurities;Pharmaceuticals;Lansoprazole;(intermediate of lansoprazole);Heterocyclic Compounds | | Mol File: | 103577-40-8.mol | ![2-[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methylthio-1H-benzimidazole Structure](CAS/GIF/103577-40-8.gif) |
| | 2-[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methylthio-1H-benzimidazole Chemical Properties |
| Melting point | 149-150°C | | Boiling point | 494.9±55.0 °C(Predicted) | | density | 1.41 | | storage temp. | Inert atmosphere,Store in freezer, under -20°C | | solubility | DMSO (Slightly), Methanol (Slightly) | | pka | 10.60±0.10(Predicted) | | form | Crystalline Powder | | color | White to Pale Orange | | λmax | 292nm(EtOH)(lit.) | | CAS DataBase Reference | 103577-40-8(CAS DataBase Reference) |
| Safety Statements | 24/25 | | HS Code | 29309090 |
| | 2-[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methylthio-1H-benzimidazole Usage And Synthesis |
| Chemical Properties | Pale Yellow Solid | | Uses | Lansoprazole Sulfide (Lansoprazole EP Impurity C; USP Impurity B) is a metabolite of Lansoprazole, as gastric pump inhibitor. |
| | 2-[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methylthio-1H-benzimidazole Preparation Products And Raw materials |
|
